Cargando…
Gastrointestinal (GI)-Specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a South American cohort
BACKGROUND: Immunosuppressive therapies have burdensome side effects which may lead to sub-therapeutic dosing and non-compliance. Patients on different immunosuppressant regimens may feel less bothered by Gastrointestinal (GI) side effects or report better health-related quality of life (HRQL). We e...
Autores principales: | Machnicki, Gerardo, Pefaur, Jacqueline, Gaite, Luis, Linchenco, Ana M, Raimondi, Clemente, Schiavelli, Ruben, Otero, Alcira, Margolis, Mary Kay |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2499997/ https://www.ncbi.nlm.nih.gov/pubmed/18644133 http://dx.doi.org/10.1186/1477-7525-6-53 |
Ejemplares similares
-
GI involvement in monkeypox
por: Fernandez, Hernando Marulanda, et al.
Publicado: (2023) -
Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies
por: Dillon, Alexander B., et al.
Publicado: (2015) -
The Role of Selected Serpins in Gastrointestinal (GI) Malignancies
por: Pączek, Sara, et al.
Publicado: (2022) -
First Complete Genome Sequences of Human Sapovirus Strains Classified as GI.3, GI.4, GI.6, GI.7, and GII.7
por: Oka, Tomoichiro, et al.
Publicado: (2018) -
Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations
por: Vespa, Edoardo, et al.
Publicado: (2021)